Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium versus cariprazine for acute bipolar depression (DUAG 9)
2024-517170-20-01Phase 4Authorised
- Sponsor
- Aalborg University Hospital
- Start
- Dec 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in bipolar disorder (BD) comparing Lithium arm with Cariprazine arm (2 arms). Primary endpoint: Change in HDS-6. Planned start Dec 2022; status: authorised.
02
Drugs
lithiumcariprazine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2024-517170-20-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517170-20-01.